Real-time enrollment status for this diffuse intrinsic pontine glioma clinical trial
Current Status
Recruiting
Checked: November 6, 2026 at 10:53 AM UTC
| NCT Number | NCT07680439 |
| Recruiting Status | Recruiting |
| Condition | Diffuse Intrinsic Pontine Glioma |
| Phase | PHASE2 |
| Target Enrollment | 75 participants |
| Active Locations | 6 sites in the US |
| Sponsor | BrainChild Bio, Inc |
| Last Updated on CT.gov | October 28, 2026 (1 week ago) |
As of November 6, 2026: Clinical trial NCT07680439 is currently recruiting participants. This phase2 study for diffuse intrinsic pontine glioma is actively seeking new participants at 6 locations across the United States. The study is sponsored by BrainChild Bio, Inc. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07680439 is actively recruiting participants as of November 6, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 6 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07680439 was last updated 1 week ago (October 28, 2026). HelloStudys verifies this status automatically.